Cargando…
The use of commercial fibrin glue in dermal replacement material reduces angiogenic and lymphangiogenic gene and protein expression in vitro
BACKGROUND: Commercial fibrin glue is increasingly finding its way into clinical practice in surgeries to seal anastomosis, and initiate hemostasis or tissue repair. Human biological glue is also being discussed as a possible cell carrier. To date, there are only a few studies addressing the effects...
Autores principales: | Fuchs, Benedikt, Birt, Alexandra, Moellhoff, Nicholas, Kuhlmann, Constanze, Giunta, Riccardo, Wiggenhauser, Paul Severin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226008/ https://www.ncbi.nlm.nih.gov/pubmed/37082911 http://dx.doi.org/10.1177/08853282231171681 |
Ejemplares similares
-
Adipose-Derived Stem Cells Improve Angiogenesis and Lymphangiogenesis in a Hypoxic Dermal Regeneration Model In Vitro
por: Fuchs, Benedikt, et al.
Publicado: (2023) -
Tissue reactions to polyethylene glycol and glutaraldehyde-based surgical sealants in a rabbit aorta model
por: Slezak, Paul, et al.
Publicado: (2020) -
The eggshell membrane: A potential biomaterial for corneal wound healing
por: Mensah, Rosemond A, et al.
Publicado: (2021) -
A new cell-sized support for 3D cell cultures based on recombinant spider
silk fibers
por: Stern-Tal, Dganit, et al.
Publicado: (2021) -
Swelling of kappa carrageenan hydrogels in simulated body fluid for
hypothetical vessel occlusion applications
por: Wurm, Florian, et al.
Publicado: (2022)